Clinical profile, species-specific severity grading, and outcome determinants of snake envenomation

An Indian tertiary care hospital-based prospective study

Kavitha Saravu, Vasanth Somavarapu, Ananthkrishna B. Shastry, Rishikesh Kumar

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Objective: We undertook this study to assess the clinical profile and outcome determinants of different snake envenomation as well as to assign species-specific severity grade to different cases based on clinico - laboratory evidence scale. Materials and Methods: A prospective clinico - epidemiologic evaluation for outcome determinants of snakebite envenomation was carried out based on a clinico - laboratory severity grading scale, among 76 patients over a period of 2 years, in a tertiary care hospital in southern India. Results: Majority of patients were male agricultural workers (53.9%) followed by housewives (19.7%), and students (9.2%). Occurrence of viper snake envenomation with hemotoxic syndrome (73.68%) was highest followed by cobra and krait envenomation with neurotoxic (19.73%) and hemo - neurotoxic (5.3%) syndrome, respectively. On the contrary, maximum mortality and severity was seen in krait (60%) followed by cobra (13.33%) and viper (8.9%) envenomation. The average dose of anti-snake venom (ASV) administered varied from 9.83 (±7.22) to 20.25 (±4.92) vials throughout grade I to IV in all snake species envenomation. An increase in severity grade, ASV dose, and mortality were observed with the corresponding delay in ′bite to needle time.′ Also, initial traditional treatments and krait species envenomation were significantly associated with higher grades of severity and mortality. Conclusion: There is an urgent need to spread awareness among the community for avoidance of traditional treatment and any delay in medical intervention in snakebite incidents.

Original languageEnglish
Pages (from-to)187-192
Number of pages6
JournalIndian Journal of Critical Care Medicine
Volume16
Issue number4
DOIs
Publication statusPublished - 01-10-2012

Fingerprint

Snake Bites
Tertiary Healthcare
Tertiary Care Centers
Bungarus
Prospective Studies
Antivenins
Elapidae
Snake Venoms
Mortality
Bites and Stings
Needles
India
Students
Therapeutics

All Science Journal Classification (ASJC) codes

  • Critical Care and Intensive Care Medicine

Cite this

@article{aece69e3c8c744289cff3f2bf5d4d859,
title = "Clinical profile, species-specific severity grading, and outcome determinants of snake envenomation: An Indian tertiary care hospital-based prospective study",
abstract = "Objective: We undertook this study to assess the clinical profile and outcome determinants of different snake envenomation as well as to assign species-specific severity grade to different cases based on clinico - laboratory evidence scale. Materials and Methods: A prospective clinico - epidemiologic evaluation for outcome determinants of snakebite envenomation was carried out based on a clinico - laboratory severity grading scale, among 76 patients over a period of 2 years, in a tertiary care hospital in southern India. Results: Majority of patients were male agricultural workers (53.9{\%}) followed by housewives (19.7{\%}), and students (9.2{\%}). Occurrence of viper snake envenomation with hemotoxic syndrome (73.68{\%}) was highest followed by cobra and krait envenomation with neurotoxic (19.73{\%}) and hemo - neurotoxic (5.3{\%}) syndrome, respectively. On the contrary, maximum mortality and severity was seen in krait (60{\%}) followed by cobra (13.33{\%}) and viper (8.9{\%}) envenomation. The average dose of anti-snake venom (ASV) administered varied from 9.83 (±7.22) to 20.25 (±4.92) vials throughout grade I to IV in all snake species envenomation. An increase in severity grade, ASV dose, and mortality were observed with the corresponding delay in ′bite to needle time.′ Also, initial traditional treatments and krait species envenomation were significantly associated with higher grades of severity and mortality. Conclusion: There is an urgent need to spread awareness among the community for avoidance of traditional treatment and any delay in medical intervention in snakebite incidents.",
author = "Kavitha Saravu and Vasanth Somavarapu and Shastry, {Ananthkrishna B.} and Rishikesh Kumar",
year = "2012",
month = "10",
day = "1",
doi = "10.4103/0972-5229.106499",
language = "English",
volume = "16",
pages = "187--192",
journal = "Indian Journal of Critical Care Medicine",
issn = "0972-5229",
publisher = "E-Flow Medknow Publications",
number = "4",

}

TY - JOUR

T1 - Clinical profile, species-specific severity grading, and outcome determinants of snake envenomation

T2 - An Indian tertiary care hospital-based prospective study

AU - Saravu, Kavitha

AU - Somavarapu, Vasanth

AU - Shastry, Ananthkrishna B.

AU - Kumar, Rishikesh

PY - 2012/10/1

Y1 - 2012/10/1

N2 - Objective: We undertook this study to assess the clinical profile and outcome determinants of different snake envenomation as well as to assign species-specific severity grade to different cases based on clinico - laboratory evidence scale. Materials and Methods: A prospective clinico - epidemiologic evaluation for outcome determinants of snakebite envenomation was carried out based on a clinico - laboratory severity grading scale, among 76 patients over a period of 2 years, in a tertiary care hospital in southern India. Results: Majority of patients were male agricultural workers (53.9%) followed by housewives (19.7%), and students (9.2%). Occurrence of viper snake envenomation with hemotoxic syndrome (73.68%) was highest followed by cobra and krait envenomation with neurotoxic (19.73%) and hemo - neurotoxic (5.3%) syndrome, respectively. On the contrary, maximum mortality and severity was seen in krait (60%) followed by cobra (13.33%) and viper (8.9%) envenomation. The average dose of anti-snake venom (ASV) administered varied from 9.83 (±7.22) to 20.25 (±4.92) vials throughout grade I to IV in all snake species envenomation. An increase in severity grade, ASV dose, and mortality were observed with the corresponding delay in ′bite to needle time.′ Also, initial traditional treatments and krait species envenomation were significantly associated with higher grades of severity and mortality. Conclusion: There is an urgent need to spread awareness among the community for avoidance of traditional treatment and any delay in medical intervention in snakebite incidents.

AB - Objective: We undertook this study to assess the clinical profile and outcome determinants of different snake envenomation as well as to assign species-specific severity grade to different cases based on clinico - laboratory evidence scale. Materials and Methods: A prospective clinico - epidemiologic evaluation for outcome determinants of snakebite envenomation was carried out based on a clinico - laboratory severity grading scale, among 76 patients over a period of 2 years, in a tertiary care hospital in southern India. Results: Majority of patients were male agricultural workers (53.9%) followed by housewives (19.7%), and students (9.2%). Occurrence of viper snake envenomation with hemotoxic syndrome (73.68%) was highest followed by cobra and krait envenomation with neurotoxic (19.73%) and hemo - neurotoxic (5.3%) syndrome, respectively. On the contrary, maximum mortality and severity was seen in krait (60%) followed by cobra (13.33%) and viper (8.9%) envenomation. The average dose of anti-snake venom (ASV) administered varied from 9.83 (±7.22) to 20.25 (±4.92) vials throughout grade I to IV in all snake species envenomation. An increase in severity grade, ASV dose, and mortality were observed with the corresponding delay in ′bite to needle time.′ Also, initial traditional treatments and krait species envenomation were significantly associated with higher grades of severity and mortality. Conclusion: There is an urgent need to spread awareness among the community for avoidance of traditional treatment and any delay in medical intervention in snakebite incidents.

UR - http://www.scopus.com/inward/record.url?scp=84875174440&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875174440&partnerID=8YFLogxK

U2 - 10.4103/0972-5229.106499

DO - 10.4103/0972-5229.106499

M3 - Article

VL - 16

SP - 187

EP - 192

JO - Indian Journal of Critical Care Medicine

JF - Indian Journal of Critical Care Medicine

SN - 0972-5229

IS - 4

ER -